Cargando…
The Cost Implication of Trastuzumab in Patients With HER2-Positive Breast Cancer at Moi Teaching and Referal Hospital, Eldoret, Kenya
A year course of trastuzumab revolutionized treatment for human epidermal growth factor receptor (HER2)-positive breast cancer by increasing survival rates. However, trastuzumab treatment is cost-prohibitive, and data on abbreviated courses is lacking in advanced disease. At Moi Teaching and Referra...
Autores principales: | Wabende, Lucy Najala, Bhatia, Manisha, Kiptoo, Stephen, Kisilu, Nicholas, Kiboss, Caroline, Kibiwot, Silvanus, Jepkirui, Sally, Awuor, Dorice Adhiambo, Busakhala, Naftali, Hunter-Squires, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906546/ http://dx.doi.org/10.1200/GO.22.54000 |
Ejemplares similares
-
Reducing Geographic Barriers for Breast Cancer Diagnosis
por: Adaniya, Emily, et al.
Publicado: (2022) -
HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya
por: Mohamed, Amina Ali, et al.
Publicado: (2020) -
Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya
por: Mwaliko, E., et al.
Publicado: (2023) -
Challenges of setting up flow cytometry for diagnosis of leukemia and lymphoma at Moi Teaching and Referral Hospital, Eldoret, Kenya
por: Teresa, Lotodo, et al.
Publicado: (2015) -
Clinical patterns and early outcomes of burn injuries in patients admitted at the Moi Teaching and Referral Hospital in Eldoret, Western Kenya
por: Odondi, Ruth Negesa, et al.
Publicado: (2020)